EMA Authorised: Orphacol (cholic acid) — Theravia

View source ↗

Summary

The European Medicines Agency authorised Orphacol (cholic acid) by Theravia for treating bile acid synthesis disorders, an inborn error of metabolism affecting …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Acid Synthesis Disorders

Drugs mentioned

• Orphacol (cholic acid)

Snippet

Status: Authorised. Therapeutic area: Digestive System Diseases;Metabolism, Inborn Errors. MAH: Theravia. Decision date: 20/04/2026